Dietary Iodine Deficiency, Thyroid; Functional Disturbance
Conditions
Keywords
thyroglobulin, iodine, pregnancy
Brief summary
The purpose of the investigation is to assess iodine status of pregnant women at week 16 of gestation targeting serum thyroglobulin as a biomarker of iodine deficiency. The investigators aim to assess whether pre-gestational initiation of iodine supplementation is more advantageous in comparison to supplementation start at the time of pregnancy detection.
Detailed description
Mild iodine deficiency is still a public health issue in many industrialized countries, especially during pregnancy. During the last decade there was no monitoring of the iodine status in pregnancy in Hungary. Since urinary iodine concentration (UIC) only reflects recent iodine intake and carries limited information on individual existing iodine stores, another biomarker e.g. measurement of serum thyroglobulin concentration, would be useful to gain comprehensive information. In the present study, the purpose of the investigation is to compare UIC, UIC normalized to creatinine concentration and serum thyroglobulin as biomarkers of iodine supply in pregnant women in a geographical region where previously iodine deficiency had been found. UIC, serum thyroglobulin level and thyroid function are measured, and information about iodine supplementation and smoking before and during pregnancy are recorded.
Interventions
≥ 150 µg/day iodine supplementation (iodine containing pregnancy supplement) prior to enrollment
Sponsors
Study design
Eligibility
Inclusion criteria
* healthy pregnant women at week 16 of gestation
Exclusion criteria
* thyroid disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Urinary iodine concentration | At subject enrollment | Measurement of urinary iodine concentration (by inductively coupled plasma mass spectrometry) normalized to urine creatinine concentration |
| Serum thyroglobulin concentration | At subject enrollment | Measurement of serum thyroglobulin concentration by chemiluminescent immunoassay |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Serum thyroid stimulating hormone concentration | At subject enrollment | Measurement of serum thyroid stimulating hormone concentration by electrochemiluminescence immunoassay |
| Serum free thyroxine concentration | At subject enrollment | Measurement of serum free thyroxine concentration by electrochemiluminescence immunoassay |
| Serum free triiodothyronine concentration | At subject enrollment | Measurement of serum free triiodothyronine concentration by electrochemiluminescence immunoassay |
| Serum anti-thyroglobulin autoantibody concentration | At subject enrollment | Measurement of serum anti-thyroglobulin autoantibody (TgAb) concentration by radioimmunoassay (women with TgAb concentration above 60 IU/L are considered TgAb positive) |